Inici > Esdeveniments & Notícies > Barcelona Global Update > The company STAT-Dx, specialised in developing advanced molecular diagnosis systems, owned by Ysios Capital, agrees to a takeover by QIAGEN for 191 million dollars.
The company STAT-Dx, specialised in developing advanced molecular diagnosis systems, owned by Ysios Capital, agrees to a takeover by QIAGEN for 191 million dollars.
